Chongqing Taiji Industry (Group) Co.Ltd(600129) on December 31, the board of directors deliberated and approved the company’s “14th five year plan”. In order to realize the mission of “national medicine enriching China and Tai Chi benefiting the common people”, the company will take “becoming a world-class traditional Chinese medicine enterprise” as its vision, and formulate a strategic development direction focusing on the intelligent manufacturing of modern traditional Chinese medicine and supplemented by hemp essence characteristic chemical drugs + regional commercial leading enterprises.
According to the plan, the company will give full play to the brand influence of “Taiji” well-known trademark and century old “TongJunGe”, fully tap the market value of traditional Chinese medicine, brand products and classic famous prescriptions, and create modern Chinese medicine with multiple advantages such as scientific and technological innovation and intelligent manufacturing; At the same time, build a chemical and biological drug production base characterized by hemp essence medicine and a leading pharmaceutical business enterprise in Sichuan and Chongqing.
In the plan, Chongqing Taiji Industry (Group) Co.Ltd(600129) listed scientific and technological innovation as the top of the enterprise development strategy for the first time, and as an important means to promote the high-quality development of the enterprise. In terms of R & D direction, the company has defined the “6 + 1” key areas: digestive system and metabolic drugs, respiratory system drugs, cardiovascular drugs, anti infective drugs, nervous system drugs, anti-tumor and immunomodulatory drugs + big health products; Anchored 12 product tracks: diabetes and metabolic syndrome, malignant tumors, Chinese medicine spleen and stomach syndrome, cold, chronic obstructive pulmonary disease, coronary heart disease and hyperlipidemia, hypertension and heart failure, stroke, acute and chronic pain, infectious diseases, immune diseases, depression. In order to ensure R & D investment, the company will include it in the performance evaluation of its subsidiaries. At the end of the 14th five year plan, the investment intensity of the whole company will exceed 5% (industrial sales proportion). On this basis, accelerate the construction of Taiji science and innovation center, strengthen cooperation with first-class scientific research institutions at home and abroad, establish an industry university research integration platform, improve scientific research infrastructure and expand R & D team.
In terms of marketing, the company proposed to innovate the marketing mechanism and mode to ensure the sustained and rapid growth of sales. Focus on the above “6 + 1” areas, strengthen categories, improve brands, expand varieties, innovate incentive and elimination mechanisms, promote digital marketing and build a “marketing Iron Army”; The medical market + OTC market exert two-way efforts, and the backbone products cooperate with the general medicine sales team to ensure that the annual growth of strategic varieties is more than 30%, and the annual growth of other varieties is higher than the industry average.
In addition, the plan also makes a detailed plan for strategic initiatives such as traditional Chinese medicine resources, digital modern traditional Chinese medicine manufacturing system, pharmaceutical business transformation and upgrading, great health preservation platform and carrying forward traditional Chinese medicine culture. The company said that it will unswervingly focus on the main medical and health industry and make Chongqing Taiji Industry (Group) Co.Ltd(600129) a strategic growth pole of Sinopharm in Western China through a series of reform measures; Through endogenous development and extension expansion, strive to achieve an operating revenue of 50 billion yuan at the end of the 14th five year plan, with a net profit margin not lower than the average level of the pharmaceutical industry, and strive to become a world-class traditional Chinese medicine enterprise.
It is worth noting that the “14th five year plan” of Chongqing Taiji Industry (Group) Co.Ltd(600129) also puts forward requirements for the level of financial operation and capital operation: establish a financial and operation management system suitable for the company’s operation; Promote capital and share increase, introduce strategic investors, refinance in the capital market and reduce the asset liability ratio; Actively seek mergers and acquisitions of outstanding enterprises in the industry; Complete the optimal disposal and rational operation of “two non” enterprises (non main business and enterprises with strong non-profit ability), idle or inefficient assets.
(Shanghai Securities News · China Securities Network)
